Research Investigator in Oncology Biology
Submitted by admin on Tue, 03/15/2011 - 16:46
We are seeking research investigator in the Oncology Biology group to support drug discovery efforts for the treatment of cancer.
The primary responsibilities are to design and execute experiments to understand the biology of the therapeutic target, develop and validate cell-based assays and investigate the mechanism of action of the drug candidates. This candidate is expected to present and communicate internally and to collaborators. This candidate will also be supervising a group of 2-5 research scientists.
The primary responsibilities are to design and execute experiments to understand the biology of the therapeutic target, develop and validate cell-based assays and investigate the mechanism of action of the drug candidates. This candidate is expected to present and communicate internally and to collaborators. This candidate will also be supervising a group of 2-5 research scientists.
Basic Qualifications
¡¤ A Ph.D degree in Cell Biology, Molecular or Biochemistry in oncology related field with 0-5 years experience in drug discovery
¡¤ Experience in cell based assay development in oncology
- Excellent analytical and organizational skills
- Demonstration of critical thinking skills as applied to experimental design and data evaluation
¡¤ Good oral and written communications skills in English
Preferred Qualifications
- Experience in managing scientists in a research organization
- Expertise in cell-assay development (ELISA, MSD, AlphaLISA) and other molecular /cell biology techniques including: plasmid construction, RNAi, mammalian cell transfection, western blotting, flow cytometry, immunoprecipitation
¡¤ Communication ability in Chinese strongly preferred.
About BeiGene
BeiGene is a fully integrated biotechnology company based in Beijing that is focused on discovering and developing innovative oncology drugs. Our compound portfolio will encompass novel drugs that evolve out of our discovery laboratories in China and those selected from in-licensing partners for their potential to have high impact in the treatment of Chinese and Asian cancers.
To complement our discovery and development capabilities, BeiGene is creating a robust platform in China to enable the identification of specific subsets of patient populations that will identify patients who are most likely to benefit from the use of specific drugs or treatments. Understanding the link between treatment sensitivity and molecular targets will direct us to develop future drug candidates with greater efficacy and safety.
We are building core excellence in:
•novel drug discovery in the areas of both small molecules and biologicals
•translational research with an emphasis on biomarker identification and validation in patients
•bioinformatics based on human tumor genotyping and expression profiling
•clinical development
We are recruiting scientists who are passionate about research and innovation and who have the entrepreneurial spirit to build a lasting organization in China known for its impact on cancer.
Source::
Internet